Hôpital Fondation Adolphe de Rothschild
Paris, 75019, France
NCT Number: NCT07089355
The goal of this pilot study is to evaluate the safety and efficacy of the Toro 88 Super Bore Aspiration Catheter in acute ischemic stroke patients.
Trial opening soon.
Get Notified18 year–90 year
All sexes
Interventional
Not applicable
Paris, 75019, France
This is a prospective, open-label, single-arm, single-center clinical investigation evaluating the safety and efficacy of the Toro 88 Super Bore Aspiration Catheter in mechanical thrombectomy for acute ischemic stroke. The study is being conducted at the Hôpital Fondation Adolphe de Rothschild in France.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Toro 88 Super Bore Aspiration Catheter is a neurovascular device designed for clot aspiration during mechanical thrombectomy procedures.
Time frame: From start of procedure to 24-36 hours post-procedure
Time frame: Immediately after final device pass (intra-procedural)
Time frame: Intra-procedural
Time frame: Immediately after first device pass (intra-procedural)
Time frame: Immediately after first device pass (intra-procedural)
Time frame: 22 to 36 hours after reperfusion
Symptomatic intracranial haemorrhage according to the SITS-MOST definition (Lancet 2007) : occurrence of an intraparenchymal haematoma (PH-2) on imaging, within 22-36 hours after reperfusion treatment, associated with a clinical worsening defined by a worsening of at least 4 NIHSS points.
Time frame: From procedure to 90 days post-procedure
Time frame: At discharge and at 90 days post-procedure
Time frame: From procedure to 90 days post-procedure
Time frame: From procedure to 90 days post-procedure
Time frame: At 90 days post-procedure
Contact information is provided by the study sponsor or research team.
Toro Neurovascular, Inc.
Industry
Open-Label, Single-Arm Study Evaluating Toro 88 Super Bore Aspiration Catheter Safety and Efficacy in Mechanical Thrombectomy for Acute Ischemic Stroke in France
Acronym: TORO EFFECT FR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07601659
Acute Ischemic Stroke, Brain Diseases
View Trial DetailsNCT07571954
Acute Ischemic Stroke, Brain Diseases
Bordeaux, France
View Trial DetailsNCT07536074
Acute Ischemic Stroke, Brain Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07536165
Acute Ischemic Stroke, Brain Diseases
Guangzhou, Guangdong, China
View Trial Details